Cargando…

Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells

Aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, has been studied extensively in carcinogenesis through the genomic pathway. In recent years, AHR has also been reported to exert positive or negative effects on epithelial–mesenchymal transition (EMT), the crucial step in tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ching-Hao, Liu, Chen-Wei, Tsai, Chi-Hao, Peng, Yi-Jen, Yang, Yu-Hsuan, Liao, Po-Lin, Lee, Chen-Chen, Cheng, Yu-Wen, Kang, Jaw-Jou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399057/
https://www.ncbi.nlm.nih.gov/pubmed/27752740
http://dx.doi.org/10.1007/s00204-016-1870-0
_version_ 1783230563718529024
author Li, Ching-Hao
Liu, Chen-Wei
Tsai, Chi-Hao
Peng, Yi-Jen
Yang, Yu-Hsuan
Liao, Po-Lin
Lee, Chen-Chen
Cheng, Yu-Wen
Kang, Jaw-Jou
author_facet Li, Ching-Hao
Liu, Chen-Wei
Tsai, Chi-Hao
Peng, Yi-Jen
Yang, Yu-Hsuan
Liao, Po-Lin
Lee, Chen-Chen
Cheng, Yu-Wen
Kang, Jaw-Jou
author_sort Li, Ching-Hao
collection PubMed
description Aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, has been studied extensively in carcinogenesis through the genomic pathway. In recent years, AHR has also been reported to exert positive or negative effects on epithelial–mesenchymal transition (EMT), the crucial step in tumor malignant progression. However, the detailed mechanism remains controversial. Analysis of AHR-expression levels in non-small cell lung cancer cell lines and lung cancer tissues revealed an inverse correlation between AHR protein levels and tumor cell invasion and metastasis. Overexpression of wild-type AHR in H1299 cells (AHR poorly expressed, potently invasive) not only accelerated mesenchymal vimentin degradation, but also prevented cell invasion in vitro and in vivo. In the absence of AHR agonists, the overexpressed AHR protein was predominantly localized in the cytoplasm, where it interacted with vimentin and functioned as an E3 ubiquitin ligase. A 6-h incubation with the proteasome inhibitor MG-132 fully rescued vimentin from AHR-mediated proteasomal degradation. In AHR-overexpressing H1299 cells, either vimentin degradation or invasive suppression could be reversed when glycogen synthase kinase 3 beta (GSK3β) was inactivated by CHIR-99021 treatment. In contrast, silencing of AHR in A549 cells (AHR highly expressed, weakly invasive) resulted in the downregulation of epithelial biomarkers (E-cadherin and claudin-1), augmentation of mesenchymal vimentin level, and GSK3β Ser-9 hyper-phosphorylation, which led to enhanced invasiveness. This work demonstrates that cytoplasmic, resting AHR protein may act as an EMT suppressor via a non-genomic pathway. Depletion of cytoplasmic AHR content represents a potential switch for EMT, thereby leading to the scattering of tumor cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-016-1870-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5399057
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-53990572017-05-05 Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells Li, Ching-Hao Liu, Chen-Wei Tsai, Chi-Hao Peng, Yi-Jen Yang, Yu-Hsuan Liao, Po-Lin Lee, Chen-Chen Cheng, Yu-Wen Kang, Jaw-Jou Arch Toxicol Molecular Toxicology Aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, has been studied extensively in carcinogenesis through the genomic pathway. In recent years, AHR has also been reported to exert positive or negative effects on epithelial–mesenchymal transition (EMT), the crucial step in tumor malignant progression. However, the detailed mechanism remains controversial. Analysis of AHR-expression levels in non-small cell lung cancer cell lines and lung cancer tissues revealed an inverse correlation between AHR protein levels and tumor cell invasion and metastasis. Overexpression of wild-type AHR in H1299 cells (AHR poorly expressed, potently invasive) not only accelerated mesenchymal vimentin degradation, but also prevented cell invasion in vitro and in vivo. In the absence of AHR agonists, the overexpressed AHR protein was predominantly localized in the cytoplasm, where it interacted with vimentin and functioned as an E3 ubiquitin ligase. A 6-h incubation with the proteasome inhibitor MG-132 fully rescued vimentin from AHR-mediated proteasomal degradation. In AHR-overexpressing H1299 cells, either vimentin degradation or invasive suppression could be reversed when glycogen synthase kinase 3 beta (GSK3β) was inactivated by CHIR-99021 treatment. In contrast, silencing of AHR in A549 cells (AHR highly expressed, weakly invasive) resulted in the downregulation of epithelial biomarkers (E-cadherin and claudin-1), augmentation of mesenchymal vimentin level, and GSK3β Ser-9 hyper-phosphorylation, which led to enhanced invasiveness. This work demonstrates that cytoplasmic, resting AHR protein may act as an EMT suppressor via a non-genomic pathway. Depletion of cytoplasmic AHR content represents a potential switch for EMT, thereby leading to the scattering of tumor cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-016-1870-0) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-10-17 2017 /pmc/articles/PMC5399057/ /pubmed/27752740 http://dx.doi.org/10.1007/s00204-016-1870-0 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Molecular Toxicology
Li, Ching-Hao
Liu, Chen-Wei
Tsai, Chi-Hao
Peng, Yi-Jen
Yang, Yu-Hsuan
Liao, Po-Lin
Lee, Chen-Chen
Cheng, Yu-Wen
Kang, Jaw-Jou
Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
title Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
title_full Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
title_fullStr Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
title_full_unstemmed Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
title_short Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
title_sort cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
topic Molecular Toxicology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399057/
https://www.ncbi.nlm.nih.gov/pubmed/27752740
http://dx.doi.org/10.1007/s00204-016-1870-0
work_keys_str_mv AT lichinghao cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells
AT liuchenwei cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells
AT tsaichihao cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells
AT pengyijen cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells
AT yangyuhsuan cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells
AT liaopolin cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells
AT leechenchen cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells
AT chengyuwen cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells
AT kangjawjou cytoplasmicarylhydrocarbonreceptorregulatesglycogensynthasekinase3betaacceleratesvimentindegradationandsuppressesepithelialmesenchymaltransitioninnonsmallcelllungcancercells